After CTL transfer, most tumor cells promptly turned red, although the presence only of spotty apoptotic or necrotic areas accompanied the diffuse infiltration of CTLs. tumor cells and induce tumor regression. 2To develop effective immunotherapy, we conducted gene expression analysis of the whole tumor after ACT into tumor-bearing mice. Antigen-specific CTLs infiltrated into the tumor as early as day 1, peaked on day 3 to 5 and suppressed tumor growth, while tumors grew gradually in untreated mice. three or more, 4Histological analysis demonstrated that the number of CTLs in the tumor was far lower than the number of tumor cells on day three or more after WORK; we hypothesized that this small number of CTLs infiltrating the tumor would inadequate to prevent its growth specifically by direct cell-to-cell cytotoxicity. Indeed, only small areas CD178 of necrosis or apoptosis were observed after ACT. Gene expression analysis revealed that genes related to CD8+T cells, the MHC Class I pathway, IFN signaling, cytotoxic effector molecules, while others were upregulated in tumors from ACT-treated mice. In contrast, genes related to the cell cycle, such asSkp2, E2f2, Ccnf, Mki67andWee1, were downregulated. Therefore , to examine the cell cycle regulation of malignant cells in the presence of antitumor CTLs, we developed a new mouse model using B16 melanoma cells expressing a fluorescent ubiquitination-based cell routine indicator (B16-fucci) and infusions of transgenic T cells expressing premelanosome protein-specific To cell receptor (pmel-1-TCR). five, 6In the S, G2, and M phases from the cell routine, B16-fucci cells fluoresce green, in the G1 phase red, and during the G1/S transition, green and red merge, and nuclei fluoresce yellow-colored. The majority of B16-fucci tumor cells inoculated subcutaneously into C57BL/6 mice were in the S/G2/M phase in the growing tumor and fluoresced green. After CTL transfer, most tumor cells promptly turned red, although the presence only of spotty apoptotic or necrotic areas accompanied the diffuse infiltration of CTLs. These results suggest that only a minority of tumor cells was identified and wiped out by CTLs infiltrating the tumor; nonetheless, the majority of tumor cells underwent cell routine arrest in G1 with out direct contact with CTLs (Fig. 1). == Figure 1 . Berbamine == CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity. B16 melanoma cells expressing a fluorescent ubiquitination-based cell cycle indication (B16-fucci) fluoresce green in the S, G2, and M phases from the cell routine, red in the G1 phase and yellow-colored during the G1/S transition. Cytotoxic T lymphocytes (CTLs) infiltrate the tumor, where they recognize and directly kill a portion from the cancer cells. At the same time, interferon (IFN) secreted by CTLs induces wide spread G1 cell cycle arrest of additional tumor cells through the IFN receptor, phosphorylation Berbamine of Stat1, downregulation of Skp2 and build up of its target p27 cyclin-dependent kinase inhibitor. The inhibition of tumor growth mediated by tumor-reactive CTLs is thus largely determined by IFN-mediated cell cycle arrest rather than the cytolytic killing of tumor cells. Treating WORK mice with IFN neutralizing antibody (Ab) abrogated the inhibitory effects of CTLs on tumor growth. Tumors fluoresced green again when signal transducer and activator of transcription 1 (Stat1) phosphorylation and manifestation of IFN inducible genes, such as MIG (Cxcl9), IP10 (Cxcl10), or I-TAC (Cxcl11), was prevented by IFN blockade. However , expression from the lytic molecules perforin, granzyme B or FasL was unaffected. To examine the direct effects of IFN on B16 tumor cell growth, we generated B16-fucci tumor cells with an IFN receptor lacking the intracellular component (B16-fucciIC). 7Exposure to IFN completely inhibited the proliferation of B16-fucci cells and arrested them in G1 phase, but had no effect Berbamine on B16-fucciIC cells. Thus, CTLsin vivoor IFN treatmentin vitroinduced G1 cell routine arrest, a response that was blocked with an antibodyin vivoor in B16-fucci cells with defective IFN receptors. These results therefore show that tumor growth reduction mediated by ACT is largely dependent on IFN-mediated cell routine arrest rather than the direct eliminating of tumor cells. IFN is known to inhibit cell proliferation. In ACT-treated B16 melanoma cells, IFN-mediated G1 cell cycle arrest was associated with signal transduction through IFN receptor, phosphorylation of Stat1, downregulation of Skp2 and accumulation of its target p27 Cyclin-dependent kinase inhibitor, but did not appear to involve other pathways known to mediate cell routine arrest. Similarly, the suppression of cell proliferation and G1 cell cycle arrest through pStat1, Skp2 and p27 were also observed in FBL-3 and to a lesser extent in other tumor cells, (e. g., p815, CT26 and 3LL). However , EL-4 cells were insensitive to IFN because they lack signal transduction through the.
After CTL transfer, most tumor cells promptly turned red, although the presence only of spotty apoptotic or necrotic areas accompanied the diffuse infiltration of CTLs